Review Process
APPLICATION TIME LINE
Receipt Deadline: January 15, 2009
Review: February & March 2009
Applicant Notification: June 1, 2009
Funding starts: July 1, 2009
Year 1 Grant Cycle July 1, 2009 to June 30, 2010
REVIEW PROCEDURES
Scientific peer review is conducted by the PKD Foundation’s Translational Research Review Subcommittee according to the review criteria listed below. The Foundation’s Board of Trustees will consider the recommendations of the Review Subcommittee and will determine the number of awards to be funded, based on scientific merit and availability of funds.
Applications are judged on the following review criteria:
• The conceptual basis on which the proposal rests.
• The novelty of the concept and strategy.
• The clarity of presentation.
• The overall plan for bringing the research findings to clinical application.
• The likelihood that the proposed project will contribute to or result in a viable therapeutic intervention for PKD patients.
• The experience, background and qualifications of investigators.
• The adequacy of the applicant’s resources and environment (facilities, patient population, data management, and data analysis).
• The adequacy of provisions for the protection of human subjects (if applicable).
• Institutional review board approval (if applicable).
FUNDING
The funds awarded must be used solely for the purposes specified in the proposal submitted to and approved by the PKD Foundation as executed by the investigator and institution in strict compliance with the budget attached to the application. Please note the following restrictions on salary, travel and indirect costs:
• No more than 50% of the direct costs (or $45,454) may be used for salaries. Any use of the award for salary support for the applicant must be justified in the application.
• No more than $1500 per year may be used for travel.
• Indirect costs are limited to 10% of the total direct costs or $9,091. The total award amount is $100,000.
• Successful applicants may not hold any other research funding from the PKD Foundation at the time funding of this grant begins (July 1, 2009).
• Applicants with existing funding from other sources will be eligible to apply for this award as long as there is no scientific overlap between the new application and existing or anticipated funding.
REPORTING REQUIREMENTS
Grantees must submit annual progress reports sixty (60) days prior to the grant anniversary date in each year the grant is in effect. As part of this report, a brief (one or two paragraph) summary written for the lay public must be included. Progress reports will be reviewed by the PKD Foundation in order to evaluate the progress of each project. Although Translational Research Awards are for a two year period, the PKD Foundation reserves the right to terminate any grant if the Foundation’s scientific advisors determine there has been inadequate research progress.
Within ninety (90) days of the expiration of the grant period, the grantee must submit a summation of the research which must include a detailed explanation of all research outcomes. As a part of this report, there must be a summary (one to two pages) written for the lay public. Copies of all publications and/or news releases concerning the research must also be submitted.
The financial officer of the sponsoring institution must submit annual reports detailing how the grant funds were expended during the year. These reports are due no later than ninety (90) days after each grant anniversary date. The sponsoring institution must also submit a cumulative final accounting immediately upon completion or termination of the grant. Any unexpended funds must be returned to the PKD Foundation within ninety (90) days from the termination of the grant.
ATTRIBUTION
A stipulation to all awards is appropriate attribution of the PKD Foundation in any publication, news release, presentation, etc. that results from work funded by the award. The PKD Foundation must also receive a copy of the publication and/or news release.
LIABILITY POLICY & REPORTING RESPONSIBILITIES
The PKD Foundation serves as a grantor not a sponsor for translational research projects. For those involving human subjects, the responsibility for liability issues and all reporting requirements including local, state and federal regulations and requirements including those of the FDA, will reside with the sponsoring institution, not the PKD Foundation.
CONFLICT OF INTEREST
Any relationship between the investigators and any industrial collaborator must be disclosed in the application.
CLICK HERE TO RETURN TO 2008 TRANSLATIONAL RESEARCH GRANT AWARD HOME PAGE